Clinical Trial Update: Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is assessing the safety and efficacy of sacituzumab tirumotecan in combination with pucotenlimab for advanced cholangiocarcinoma, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Pucotenlimab
• Sacituzumab Tirumotecan (Sacituzumab govitecan)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Cholangiocarcinoma | Phase 2 | Status: RECRUITING